1-2 of 2
Michael S. Wertheim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT056: Preliminary safety, efficacy, and pharmacodynamics of a highly selective PI3Kδ inhibitor, INCB050465, in patients with previously treated B-cell malignancies

Andres Forero-Torres, Michael S. Wertheim, Tycel J. Phillips, Martin E. Gutierrez, William J. Edenfield, Swamy Yeleswaram, Maureen Bleam, Li Zhou, Jennifer H. Pulini, Théa Faivre, Harry Miao, Matt Spear, Rod Ramchandren
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT056.
https://doi.org/10.1158/1538-7445.AM2016-CT056
Published: 15 July 2016
View articletitled, Abstract CT056: Preliminary safety, efficacy, and pharmacodynamics of a highly selective PI3Kδ inhibitor, INCB050465, in patients with previously treated B-cell malignancies
Journal Articles

Phase I Trial and Clinical Pharmacological Evaluation of 10-Ethyl-10-deazaaminopterin in Adult Patients with Advanced Cancer

Mark G. Kris, James J. Kinahan, Richard J. Gralla, Michael P. Fanucchi, Michael S. Wertheim, Joseph P. O'Connell, Linda D. Marks, Linda Williams, Fouad Farag, Charles W. Young, Francis M. Sirotnak
Journal: Cancer Research
Cancer Res (1988) 48 (19): 5573–5579.
Published: 01 October 1988
View articletitled, Phase I Trial and Clinical Pharmacological Evaluation of 10-Ethyl-10-deazaaminopterin in Adult Patients with Advanced Cancer
Open the PDF for Phase I Trial and Clinical Pharmacological Evaluation of 10-Ethyl-10-deazaaminopterin in Adult Patients with Advanced Cancer in another window